p53 activation inhibits the development of MLL-fusion leukemia with the assistance of tumor immunity

Yasutaka Hayashi

Presentation information

Oral Session

Oral Session 2-11B AML: Novel therapeutic targets

Sat. Oct 13, 2018 10:10 AM - 11:10 AM No.11 (Osaka International Convention Center, 10F 1004-5)

Chair: Yoichi Imai (Research Hospital, The Instisute of Medical Science, The University of Tokyo, Japan)

[OS2-11B-5] p53 activation inhibits the development of MLL-fusion leukemia with the assistance of tumor immunity

Yasutaka Hayashi¹, Susumu Goyama¹, Xiaoxiao Liu¹, Shiori Shikata¹, Yosuke Tanaka¹, Tomofusa Fukuyama¹, Akiko Matsumoto², Satoshi Yamasaki², Tatsuhiro Shibata², Hitoshi Takizawa³, Toshio Kitamura¹ (1.Cellular Therapy, IMSUT, Tokyo Univ., Tokyo, Japan, 2.Laboratory of Molecular Medicine, HGC, IMSUT, Tokyo Univ., Tokyo, Japan, 3.International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan)

Abstract password authentication.
Password is written on a program and abstract book.